Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Fei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4675-7207; OpenAlex author ID A5100412179. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation. Last author DOI 10.7150/ijbs.70567↗
  2. ZFX Promotes Proliferation and Metastasis of Pancreatic Cancer Cells via the MAPK Pathway. Co-author DOI 10.1159/000491727↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zihang Xu · 1 shared paper, 2022 · strength 0.13
  2. Xiao Chen · 1 shared paper, 2022 · strength 0.13
  3. Yingbin Liu · 1 shared paper, 2018 · strength 0.07
  4. Jun Fei Gu · 1 shared paper, 2018 · strength 0.07
  5. Xiaoling Song · 1 shared paper, 2018 · strength 0.07
  6. Jianhua Lu · 1 shared paper, 2018 · strength 0.07
  7. Wei Gong · 1 shared paper, 2018 · strength 0.07
  8. Minghui Zhu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.